Costs and consequences of stem cell transplantation in children

Pediatric Transplantation

Volumn 7, Issue SUPPL. 3, 2003, Pages 7-11

  Barr, Ronald D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Children; Economic; Evaluation; Transplantation

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL TYPE; CLINICAL TRIAL; CONFERENCE PAPER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DISABILITY; DONOR; ECONOMIC EVALUATION; HUMAN; LYMPHOMA; MORTALITY; NONHODGKIN LYMPHOMA; PATIENT SATISFACTION; QUALITY OF LIFE; SOLID TUMOR; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0037222390     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.7.s3.1.x     Document Type: Conference Paper

References (39)

1. JOHNSON PW, SIMNETT SJ, SWEETENHAM JW, MORGAN GJ, STEWART LA. Bone marrow and peripheral blood stem cell transplantation for malignancy. Health Technol Assess 1998: 2: 1-187.
2. WEEKS FM, YEE GC, BARTFIELD AA, WINGARD JR. The true cost of bone marrow transplantation. Am J Med Sci 1997: 314: 101-112.
3. HARTMANN O, LE CORROLLER AG, BLAISE D, et al. Peripheral blood stem cell and bone marrow transplantation for solid tumours and lymphomas: Hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 1997: 126: 600-607.
4. BARR RD, FURLONG W, HORSMAN JR, et al. The monetary costs of childhood cancer to the families of patients. Int J Oncol 1996: 8: 933-940.
5. GOLD MR, SIEGEL JE, RUSSELL LB, WEINSTEIN MC. Cost Effectiveness in Health and Medicine. New York: Oxford University Press, 1996: 1-425.
6. DURBIN M. Bone marrow transplantation: Economic, ethical and social issues. Pediatrics 1988: 82: 774-783.
7. FLETCHER RH, FLETCHER SW, WAGNER EH. Clinical Epidemiology: The Essentials. Baltimore: Williams & Wilkins, 1996: 5: 2-6.
8. FEENY D, FURLONG W, MULHERN RK, BARR RD, HUDSON M. A framework for assessing health-related quality of life among children with cancer. Int J Cancer Suppl 1999: 12: 2-9.
9. KAPLAN RM, ANDERSON JP. The general health policy model: An integrated approach. In: SPILKER B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd edn. Philadelphia: Lippincott-Raven Press, 1996: 309-322.
10. RABIN R, DE CHARRO F, EQ-5D: a measure of health status from the EuroQOL Group. Ann Med 2001: 33: 337-343.
11. FURLONG WJ, FEENY DH, TORRANCE GW, BARR RD. The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies. Ann Med 2001: 33: 375-384.
12. BOGGS SR, GRAHAM-POLE J, MILLER EM. Life-threatening illness and invasive treatment. The future of quality of life assessment and research in pediatric oncology. In: JOHNSON JH, JOHNSON SB, eds. Advances in Child Health Psychology. Gainesville: University of Florida Press, 1991: 353-361.
13. SEID M, VARNI JW, RODE CA, KATZ ER. The Pediatric Cancer Quality of Life Inventory: a modular approach to measuring health-related quality of life in children with cancer. Int J Cancer Suppl 1999: 12: 71-76.
14. GUYATT GH, FEENY DH, PATRICK DL. Measuring healthrelated quality of life. Ann Intern Med 1993: 118: 622-629.
15. TORRANCE GW. Designing and conducting cost-utility analyses. In: SPILKER B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia: Lippincott-Raven Publishers, 1996: 1105-1111.
16. JERJIS SH, CROOCKWEIT S, MUUS P, et al. Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patient with non-Hodgkin's lymphoma and acute lymphoblastic leukemia. Leuk Lymph 1999: 36: 33-43.
17. RIZZO JD, VOGELSANG GB, KRUMM S, et al. Outpatient-based bone marrow transplantation for hematologic malignancies: Cost saving or cost shifting? J Clin Oncol 1999: 17: 2811-2818.
18. GRANT M, FERRELL B, SCHMIDT GM, et al. Measurement of quality of life in bone marrow transplantation survivors. Qual Life Res 1992: 1: 375-384.
19. MCQUELLON RP, RUSSELL GB, CELLA DF, et al. Quality of life measurement in bone marrow transplantation. Development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transpl 1997: 19: 357-368.
20. KOPP M, SCHWEIGKOFLER H, HOLZNER B, et al. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: A comparison. Eur J Haematol 2000: 65: 97-103.
21. ZITTOUN R, ARCHARD S, RUSZNIEWSKI M. Assessment of quality of life during intensive chemotherapy or bone marrow transplantation. Psycho-Oncology 1999: 8: 64-73.
22. BADELL I, IGUAL L, GOMEZ P, et al. Quality of life in young adults having received a BMT during childhood: a GETMON study. Bone Marrow Transpl 1998: 21 (Suppl. 2): S68-S71.
23. KANABAR DJ, ATTARD-MONTALTO S, SAHA V, et al. Quality of life in survivors of childhood cancer after mega therapy with autologous bone marrow rescue. Pediatr Hematol Oncol 1995: 12: 29-36.
24. PARSONS SK, GELBER S, COLE BF, et al. Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group study 8821. J Clin Oncol 1999: 17: 2144-2152.
25. NESPOLI L, VERRI AP, LOCATELLI F, et al. The impact of pediatric bone marrow transplantation on quality of life. Qual Life Res 1995: 4: 233-240.
26. MATTHES-MARTIN S, LAMCHE M, LADENSTEIN R, et al. Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: A single centre retrospective analysis. Bone Marrow Transpl 1999: 23: 1049-1053.
27. SCHMIDT GM, NILAND JC, FORMAN SJ, et al. Extended follow up in 212 long-term allogeneic bone marrow transplant survivors. Transplantation 1993: 55: 551-557.
28. PARSONS SK, BARLOW SE, LEVY SL, SUPRAN SE, KAPLAN SH. Health-related quality of life in pediatric bone marrow transplant survivors. Int J Cancer Suppl 1999: 12: 46-51.
29. BARRERA M, BOYD-PRINGLE LA, SUMBLER K, SAUNDERS F. Quality of life and behavioral adjustment after pediatric bone marrow transplantation. Bone Marrow Transpl 2000: 26: 427-435.
30. PHIPPS S, DUNAVANT M, JAYAWARDENE D, SRIVASTIVA DK. Assessment of health-related quality of life in acute inpatient settings: Use of the BASES instrument in children undergoing bone marrow transplantation. Int J Cancer Suppl 1999: 12: 18-24.
31. RODRIGUE JR, MACHAUGHTON K, HOFFMAN RS, et al. Perceptions of parenting stress and family revelations by fathers of children evaluated for organ transplantation. Psychol Rep 1996: 79: 723-727.
32. BARR R, FURLONG W, HENWOOD J, et al. Economic evaluation of allogeneic bone marrow transplantation. A rudimentary model to generate estimates for the timely formulation of clinical policy. J Clin Oncol 1996: 14: 1413-1420.
33. DUFOIR T, SAUX MC, TERRAZA B, et al. Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukemia in first remission. Bone Marrow Transplant 1992: 10: 323-329.
34. UYL-DE GROOT CA, HAGENBEEK A, VERDONCK LF, LOWENBERG B, RUTTEN FFH. Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL). Bone Marrow Transplant 1995: 16: 463-470.
35. BEARD MEJ, INDER AB, ALLEN JR, et al. The costs and benefits of bone marrow transplantation. NZ Med J 1991: 104: 303-305.
36. LECOROLLER AG, FAUCHER C, AUPERIN A, et al. Autologous peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation for adults and children with non-leukemic malignant disease. A randomized economic study, Pharmacoeconomics 1997: 11: 454-463.
37. LAUPACIS A, FEENY D, DETSKY AS, TUGWELL PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992: 146: 473-481.
38. LEE SJ, ANASETTI C, KUNTZ KM, et al. The costs and cost effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia. Blood 1998: 92: 4047-4052.
39. TENGS TO, ADAMS ME, PLISKIN JS, et al. Five hundred life saving interventions and their cost-effectiveness. Risk Anal 1995: 15: 369-390.